drugset / Trial / NCT00596466

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

NCT00596466

Phase 3 Completed 75 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.

Timeline

Start
2008-04
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications